Journal of Cardiovascular Disease Research
Complete Heart Block Following Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention – CASE SERIES
1DR.MADIVALSWAMI D, 2DR.SANJEEV SAJJANAR, 3DR.MILIND R KULKARNI
JCDR. 2023: 1191-1199
Abstract
BACKGROUND Acute coronary syndrome (ACS) patients can be successfully treated with percutaneous coronary intervention (PCI). The anti-anginal drug Nicorandil works to improve microvascular circulation and boost coronary blood flow.
» PDF